-
How Moderna's Patent Challenge Loss Could Impact Coronavirus Vaccine Program
Friday, July 24, 2020 - 11:25am | 564Moderna Inc (NASDAQ: MRNA) shares came under significant selling pressure Thursday afternoon following an adverse patent ruling, and the stock is adding to the losses in Friday's session. Moderna Loses Patent Challenge: In an ongoing legal dispute, the Patent Trial and Appeal Board...